Kazia Therapeutics Stock (NASDAQ: KZIA) stock price, news, charts, stock research, profile.
Open | $0.39 |
Close | $0.42 |
Volume / Avg. | 1.22M / 12.50M |
Day Range | $0.38 - $0.44 |
52 Wk Range | 0.19 - 1.58 |
Market Cap | $12.57M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kazia Therapeutics (NASDAQ:KZIA) through any online brokerage.
Other companies in Kazia Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN) and Can Fite Biofarma (AMEX:CANF).
Kazia Therapeutics has a consensus price target of $10.00.
The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $0.422 last updated August 30, 2024 at 7:57 PM EDT.
There are no upcoming dividends for Kazia Therapeutics.
Kazia Therapeutics’s FY earnings are confirmed for Friday, September 13, 2024.
There is no upcoming split for Kazia Therapeutics.
Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.